The North America Periodontal Disease Treatment Market was valued at $773.8 Million in 2024 and projected to reach to $1113.2 Million by 2029, representing a compound annual growth rate of 6.2%. North America's periodontal disease treatment market is poised for sustained expansion driven by increasing disease prevalence, aging populations, and heightened oral health awareness.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's periodontal disease treatment market is valued at $773.8 million in 2024, with a projected CAGR of 6.2% through 2029, reaching $1,113.2 million. This growth outpaces the global CAGR of 5.9%, positioning North America as a high-growth region.
The region benefits from world-class dental care systems, state-of-the-art treatment facilities, and widespread access to periodontal specialists. North America's established healthcare framework supports rapid adoption of innovative treatment modalities and technologies.
Periodontal disease affects a significant portion of the North American population, with increasing awareness driving demand for professional treatment. The prevalence of gingivitis and periodontitis creates sustained market demand across all demographic segments.
North America leads in adopting cutting-edge periodontal treatments including laser therapy, regenerative procedures, and digital diagnostics. Strong investment in dental innovation and early technology adoption accelerates market expansion in the region.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
| Country | 2025 size (native) |
|---|---|
| US | USD 412.07 Million |
| Canada | USD 106.73 Million |
| Mexico | USD 23.45 Million |
The North America periodontal disease treatment market was valued at $773.8 million in 2024 and is expected to reach $1,113.2 million by 2029.
North America's periodontal disease treatment market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2029.
Key drivers include aging populations, rising periodontal disease prevalence, advanced treatment technology adoption, strong healthcare infrastructure, and comprehensive dental insurance coverage across North America.
North America shows strong adoption of both surgical and non-surgical periodontal treatments, including scaling and root planing, laser-assisted therapies, and regenerative procedures.
North America's 6.2% CAGR slightly exceeds the global average of 5.9%, reflecting the region's advanced healthcare systems and higher treatment adoption rates.
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report